Raymond Dingledine awarded national pharmacology career achievement award

The American Society of Pharmacology and Experimental Therapeutics (ASPET) has awarded Raymond J. Dingledine, PhD, professor and past chair of the Department of Pharmacology in Emory University School of Medicine, with the 2018 Robert R. Ruffolo Career Achievement Award in Pharmacology. The award will be presented during the ASPET Annual Meeting at Experimental Biology 2018 in San Diego on Saturday, April 21, 2018.

Dingledine is being recognized for his research achievements on the pharmacology of glutamate receptors and the causes of epilepsy, including his earlier work that provided seminal insights into the regulation of postsynaptic glutamate receptors. Some of these findings led him to co-found NeurOp, Inc., a company focused on novel therapeutics for neurological disorders. His recent work has led to the identification of novel EP2 prostaglandin receptor antagonists capable of reducing neuro-inflammation, with these studies revealing diverse immunomodulation pathways in epilepsy.

Dr. Dingledine is a faculty member in the MSP and NS programs.

Click here to view the full story in the Emory News Center.